Sofiene Rekik1,2, Imen Trabelsi3, Mourad Hentati3, Adnene Hammami4, Mounir Ben Jemaa5, Jamil Hachicha6, Samir Kammoun3. 1. Cardiology Department, University Hospital Hedi Chaker, Sfax, Tunisia. sofienerek@yahoo.fr. 2. , Sakiet Eddaier 3011. BP 9, Sfax, Tunisia. sofienerek@yahoo.fr. 3. Cardiology Department, University Hospital Hedi Chaker, Sfax, Tunisia. 4. Microbiology Department, University Hospital Habib Bourguiba, Sfax, Tunisia. 5. Infectious Disease Department, University Hospital Hedi Chaker, Sfax, Tunisia. 6. Nephrology and Dialysis Department, University Hospital Hedi Chaker, Sfax, Tunisia.
Abstract
BACKGROUND: Infective endocarditis (IE) is a dreaded complication in hemodialysis (HD) patients and is strongly associated with morbidity and mortality. OBJECTIVES: Our aim was to investigate clinical and echocardiographic characteristics, microbiological profile, management and outcome of patients on HD in a Tunisian (Tunisia, North Africa) high-volume tertiary-care centre. METHODS: Among 182 patients who fulfilled the modified Duke criteria for infective endocarditis between January 1997 and December 2006, 16 were on chronic HD and were included in the study. RESULTS: Mean age was 52.5 +/- 22.3 years, ten were male and arteriovenous fistulas were the most commonly used access sites (12 out of 16 cases). Average duration of dialysis was 27.3 +/- 30 months. Major causative organisms were Staphylococcus species (including methicillin-resistant Staphylococcus aureus) in 11 (68.7%) of the 16 cases. The mitral valve was the most commonly affected [9 patients out of 16 (56.2%)], followed by aortic valve in 4 cases (25.0%) and tricuspid valve in 1 case (6.2%). Complications were frequent, including congestive heart failure (56.2%), secondary septic localisations (31.2%), arterial emboli (18.7%), and cerebral haemorrhage (6.2%). Five patients underwent surgery and seven died during hospitalization (43.7% mortality rate). No recurrences of IE were recorded in the nine survivors after average 21.7 +/- 17.3 months follow-up. CONCLUSION: In this largest reported confirmed IE series in dialysis patients in a developing country, mortality was very high; mitral valve was the most commonly affected valve. Staphylococcus species were the major causative organisms.
BACKGROUND:Infective endocarditis (IE) is a dreaded complication in hemodialysis (HD) patients and is strongly associated with morbidity and mortality. OBJECTIVES: Our aim was to investigate clinical and echocardiographic characteristics, microbiological profile, management and outcome of patients on HD in a Tunisian (Tunisia, North Africa) high-volume tertiary-care centre. METHODS: Among 182 patients who fulfilled the modified Duke criteria for infective endocarditis between January 1997 and December 2006, 16 were on chronic HD and were included in the study. RESULTS: Mean age was 52.5 +/- 22.3 years, ten were male and arteriovenous fistulas were the most commonly used access sites (12 out of 16 cases). Average duration of dialysis was 27.3 +/- 30 months. Major causative organisms were Staphylococcus species (including methicillin-resistant Staphylococcus aureus) in 11 (68.7%) of the 16 cases. The mitral valve was the most commonly affected [9 patients out of 16 (56.2%)], followed by aortic valve in 4 cases (25.0%) and tricuspid valve in 1 case (6.2%). Complications were frequent, including congestive heart failure (56.2%), secondary septic localisations (31.2%), arterial emboli (18.7%), and cerebral haemorrhage (6.2%). Five patients underwent surgery and seven died during hospitalization (43.7% mortality rate). No recurrences of IE were recorded in the nine survivors after average 21.7 +/- 17.3 months follow-up. CONCLUSION: In this largest reported confirmed IE series in dialysis patients in a developing country, mortality was very high; mitral valve was the most commonly affected valve. Staphylococcus species were the major causative organisms.
Authors: Uday S Nori; Anup Manoharan; John I Thornby; Jerry Yee; Ravi Parasuraman; Venkataraman Ramanathan Journal: Nephrol Dial Transplant Date: 2006-04-27 Impact factor: 5.992
Authors: Timothy Doulton; Nikhant Sabharwal; Hugh S Cairns; Silke Schelenz; Susannah Eykyn; Patrick O'Donnell; John Chambers; Conell Austen; David J A Goldsmith Journal: Kidney Int Date: 2003-08 Impact factor: 10.612
Authors: Desikan Kamalakannan; Rama Manohara Pai; Leonard B Johnson; Julius M Gardin; Louis D Saravolatz Journal: Ann Thorac Surg Date: 2007-06 Impact factor: 4.330